Ubiquigent brings together a team of industry-proven drug discovery professionals, who work with their academic colleagues to guide clients through the rapidly evolving landscape of the ubiquitin proteasome system.
Our collaborative approach and deep scientific understanding of ubiquitin system drug discovery helps us shape a customised strategy for our clients to reduce their risk of failure and accelerate their time lines towards a successful outcome.
From an understanding of the underlying biology, through drug discovery and on to early development issues, our scientific experts are uniquely qualified to help you navigate the complexities of the ubiquitin proteasome system.
Typically, our clients are investment funds, technology transfer organisations, research charities, major pharmaceutical companies and virtual biotechs who want us to help them formulate an innovative plan or conduct due diligence on an early stage idea or new project that they need to be delivered on time and on budget.
Feel free to Contact us for a no-obligation quote or to discuss your specific needs with one of our experts.